ClinicalTrials.Veeva

Menu

Acute Kidney Injury in Patients With CoVID-19 (AKI-COVID-19)

U

Uşak University

Status

Completed

Conditions

Acute Kidney Injury
Covid19

Treatments

Other: duration of hospitalization, mortality rate

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

We aimed to investigate the effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19.

Full description

The effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19. Patients hospitalised for COVID-19 and acute kidney injury will be enrolled. The duration of hospitalisation, mortality rates will be compared in COVID-19 patients with and without acute kidney injury.

Enrollment

600 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalised with COVID-19.
  • Patients hospitalised with COVID-19 with Acute Kidney Injury

Exclusion criteria

Trial design

600 participants in 2 patient groups

COVID-19 patients with acute kidney injury
Description:
COVID-19 patients with acute kidney injury
Treatment:
Other: duration of hospitalization, mortality rate
COVID-19 patients without acute kidney injury
Description:
COVID-19 patients without acute kidney injury
Treatment:
Other: duration of hospitalization, mortality rate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems